MET and carcinoma: Another receptor tyrosine kinase, which is frequently overexpressed or deregulated in a large number of carcinomas, sarcomas, hematopoietic malignancies, and other neoplasms is the hepatocyte growth factor receptor (HGFR, c-Met or Met) [19,20].